Long-acting Reversible Contraception prescriptions - ICP Outcomes Framework - Birmingham and Solihull
Published by Birmingham and Solihull ICP
About this dataset
This dataset presents the rate of prescribing long-acting reversible contraception (LARC), excluding injections, to females aged 15 to 44 in England. It includes prescriptions for implants, intrauterine systems (IUS), and intrauterine devices (IUD) issued during the calendar year. The data is sourced from the NHS Business Services Authority (NHSBSA) and is expressed as a crude rate per 1,000 women in the target age group. Rationale Increasing the uptake of LARC is a key public health objective, as these methods are among the most effective forms of contraception. They help reduce unintended pregnancies and support reproductive autonomy. Monitoring prescription rates helps assess access to and utilisation of these contraceptive options, informing service planning and sexual health strategies. Numerator The numerator is the total number of LARC prescriptions (implants, IUS, and IUDs) issued to women of all ages during the calendar year. This data is obtained from NHSBSA’s ePACT2 prescription dataset. Denominator The denominator is the number of females aged 15 to 44, based on mid-year population estimates from the Office for National Statistics (ONS). Caveats This dataset does not include LARC prescriptions issued in abortion, maternity, or gynaecology settings. Additionally, GP prescribing data reflects all-purpose prescriptions rather than individual-level data, which may not accurately represent the number of women using LARC for contraceptive purposes. External References NHSBSA – Prescription Data (ePACT2) Public Health England – Sexual Health Profile Click here to explore more from the Birmingham and Solihull Integrated Care Partnerships Outcome Framework.
Live preview
The first rows, fetched from Opendatasoft hub when you open this page.
Loading the first rows from the source…